We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
High Tide Inc. (HITI) Suffers a Larger Drop Than the General Market: Key Insights
Read MoreHide Full Article
The latest trading session saw High Tide Inc. (HITI - Free Report) ending at $3.06, denoting a -1.92% adjustment from its last day's close. This move lagged the S&P 500's daily loss of 0.21%. On the other hand, the Dow registered a loss of 0.16%, and the technology-centric Nasdaq decreased by 0.89%.
Shares of the company witnessed a gain of 3.31% over the previous month, beating the performance of the Medical sector with its loss of 2.46% and the S&P 500's loss of 1.56%.
Analysts and investors alike will be keeping a close eye on the performance of High Tide Inc. in its upcoming earnings disclosure. The company's earnings report is set to go public on January 29, 2025. The company is forecasted to report an EPS of -$0.01, showcasing a 150% downward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $97.91 million, reflecting a 4.62% rise from the equivalent quarter last year.
Any recent changes to analyst estimates for High Tide Inc. should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Right now, High Tide Inc. possesses a Zacks Rank of #4 (Sell).
From a valuation perspective, High Tide Inc. is currently exchanging hands at a Forward P/E ratio of 234. This denotes a premium relative to the industry's average Forward P/E of 17.93.
The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 86, this industry ranks in the top 35% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
High Tide Inc. (HITI) Suffers a Larger Drop Than the General Market: Key Insights
The latest trading session saw High Tide Inc. (HITI - Free Report) ending at $3.06, denoting a -1.92% adjustment from its last day's close. This move lagged the S&P 500's daily loss of 0.21%. On the other hand, the Dow registered a loss of 0.16%, and the technology-centric Nasdaq decreased by 0.89%.
Shares of the company witnessed a gain of 3.31% over the previous month, beating the performance of the Medical sector with its loss of 2.46% and the S&P 500's loss of 1.56%.
Analysts and investors alike will be keeping a close eye on the performance of High Tide Inc. in its upcoming earnings disclosure. The company's earnings report is set to go public on January 29, 2025. The company is forecasted to report an EPS of -$0.01, showcasing a 150% downward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $97.91 million, reflecting a 4.62% rise from the equivalent quarter last year.
Any recent changes to analyst estimates for High Tide Inc. should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Right now, High Tide Inc. possesses a Zacks Rank of #4 (Sell).
From a valuation perspective, High Tide Inc. is currently exchanging hands at a Forward P/E ratio of 234. This denotes a premium relative to the industry's average Forward P/E of 17.93.
The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 86, this industry ranks in the top 35% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.